APA (7th ed.) Citation

Dinasarapu, A. R., Sutcliffe, D. J., Grychowski, L., Ozel, E., Thite, A., Visser, J. E., . . . Jinnah, H. A. (2025). Modeling rare genetic disease with patient-derived induced pluripotent stem cells: Reassessment of the minimum numbers of lines needed. Stem cells translational medicine, 14(8), . https://doi.org/10.1093/stcltm/szaf032

Chicago Style (17th ed.) Citation

Dinasarapu, Ashok R., Diane J. Sutcliffe, Lauren Grychowski, Erkin Ozel, Anika Thite, Jasper E. Visser, Ellen J. Hess, Sharon M. Kolk, and H A. Jinnah. "Modeling Rare Genetic Disease with Patient-derived Induced Pluripotent Stem Cells: Reassessment of the Minimum Numbers of Lines Needed." Stem Cells Translational Medicine 14, no. 8 (2025). https://doi.org/10.1093/stcltm/szaf032.

MLA (9th ed.) Citation

Dinasarapu, Ashok R., et al. "Modeling Rare Genetic Disease with Patient-derived Induced Pluripotent Stem Cells: Reassessment of the Minimum Numbers of Lines Needed." Stem Cells Translational Medicine, vol. 14, no. 8, 2025, https://doi.org/10.1093/stcltm/szaf032.